In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir (Q42260262)
Jump to navigation
Jump to search
scientific article published on 23 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir |
scientific article published on 23 October 2013 |
Statements
1 reference
In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir (English)
1 reference
Xiao Tong
1 reference
Sophie Le Pogam
1 reference
Lewyn Li
1 reference
Kristin Haines
1 reference
Katherine Piso
1 reference
Victoria Baronas
1 reference
Jun-Mei Yan
1 reference
Sung-Sau So
1 reference
Klaus Klumpp
1 reference
Isabel Nájera
1 reference
23 October 2013
1 reference
1 reference
209
1 reference
5
1 reference
668-675
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference